BRIMONIDINE

BRIMONIDINE was reported 17166 times

BRIMONIDINE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 PROSTAGLANDIN ANALOGUE PERIORBITOPATHY 4 0.2222
1 HYPOTONY MACULOPATHY 9 0.2195
2 INFECTIOUS CRYSTALLINE KERATOPATHY 8 0.2162
3 CONJUNCTIVAL FOLLICLES 6 0.1875
4 EXFOLIATION GLAUCOMA 4 0.1429
5 OCULAR SURFACE DISEASE 38 0.1352
6 ALLERGIC KERATITIS 3 0.1000
7 BRAIN STEM HAEMATOMA 4 0.0870
8 KERATOPLASTY 3 0.0714
9 CONJUNCTIVAL SCAR 9 0.0596
10 HYPOTONY OF EYE 25 0.0595
11 OPEN ANGLE GLAUCOMA 28 0.0456
12 CORNEAL THICKENING 3 0.0441
13 NORMAL TENSION GLAUCOMA 5 0.0431
14 CHOROIDAL DETACHMENT 21 0.0378
15 INTRAOCULAR PRESSURE FLUCTUATION 7 0.0355
16 TREATMENT FAILURE 2766 0.0334
17 CORNEAL NEOVASCULARISATION 8 0.0324
18 CHOROIDAL EFFUSION 25 0.0311
19 FIBROADENOMA OF BREAST 14 0.0311
20 SHORT STATURE 8 0.0305
21 CORNEA VERTICILLATA 9 0.0296
22 CORNEAL OEDEMA 57 0.0254
23 INTRAOCULAR PRESSURE DECREASED 13 0.0247
24 CORNEAL INFECTION 5 0.0230
25 FLAT ANTERIOR CHAMBER OF EYE 4 0.0223
26 MAGNETIC RESONANCE IMAGING HEAD ABNORMAL 14 0.0216
27 CHOROIDAL HAEMORRHAGE 4 0.0207
28 MEIBOMIAN GLAND DYSFUNCTION 9 0.0199
29 PUNCTATE KERATITIS 18 0.0196
30 THROMBOPHLEBITIS SEPTIC 4 0.0195
31 KERATITIS FUNGAL 4 0.0192
32 INTRAOCULAR PRESSURE INCREASED 233 0.0182
33 RABBIT SYNDROME 3 0.0181
34 IRIS ADHESIONS 9 0.0175
35 OCULAR HYPERTENSION 34 0.0175
36 HYPHAEMA 9 0.0172
37 OCULAR VASCULAR DISORDER 14 0.0170
38 PNEUMONIA HAEMOPHILUS 8 0.0165
39 IRIS TRANSILLUMINATION DEFECT 3 0.0160
40 GLAUCOMA SURGERY 4 0.0156
41 ANTERIOR CHAMBER INFLAMMATION 8 0.0134
42 OPTIC DISC HAEMORRHAGE 3 0.0131
43 ANTERIOR CHAMBER DISORDER 3 0.0130
44 INTRAOCULAR PRESSURE TEST 3 0.0125
45 EYE ALLERGY 19 0.0123
46 CORNEAL SCAR 6 0.0119
47 GLARE 6 0.0117
48 CYSTOID MACULAR OEDEMA 22 0.0117
49 CHRONIC LEFT VENTRICULAR FAILURE 4 0.0111
50 VISUAL ACUITY TESTS ABNORMAL 6 0.0108
51 CORNEAL TRANSPLANT 8 0.0102
52 PRODUCT DROPPER ISSUE 8 0.0102
53 IRIDOCYCLITIS 32 0.0101
54 REACTION TO PRESERVATIVES 8 0.0098
55 CORNEAL PERFORATION 6 0.0095
56 CONJUNCTIVITIS ALLERGIC 14 0.0094
57 CORNEAL DEPOSITS 7 0.0094
58 OSTEITIS DEFORMANS 3 0.0094
59 CONJUNCTIVAL HYPERAEMIA 33 0.0092
60 CATARACT NUCLEAR 6 0.0090
61 EYE INFECTION BACTERIAL 5 0.0090
62 GROWTH OF EYELASHES 7 0.0088
63 INTRAOCULAR PRESSURE TEST ABNORMAL 6 0.0085
64 KERATIC PRECIPITATES 4 0.0084
65 CATARACT SUBCAPSULAR 5 0.0082
66 CORNEAL REFLEX DECREASED 3 0.0080
67 CONJUNCTIVAL DISORDER 3 0.0079
68 CATARACT OPERATION COMPLICATION 4 0.0079
69 ANGLE CLOSURE GLAUCOMA 20 0.0078
70 GLAUCOMA 146 0.0076
71 CORNEAL DYSTROPHY 3 0.0072
72 DACRYOSTENOSIS ACQUIRED 9 0.0070
73 ENDOCRINE OPHTHALMOPATHY 6 0.0069
74 LIPIDS ABNORMAL 5 0.0069
75 RETINAL VASCULAR DISORDER 4 0.0068
76 CONJUNCTIVAL OEDEMA 7 0.0068
77 EYE LASER SURGERY 4 0.0068
78 VITRECTOMY 4 0.0067
79 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 7 0.0066
80 MACULAR OEDEMA 36 0.0064
81 CORNEAL DISORDER 14 0.0064
82 AIR EMBOLISM 3 0.0064
83 RETINAL PIGMENTATION 5 0.0063
84 KERATOPATHY 10 0.0063
85 HYPOPYON 5 0.0060
86 BLEPHARAL PIGMENTATION 3 0.0059
87 RETINAL VASCULAR THROMBOSIS 3 0.0057
88 INSTILLATION SITE ERYTHEMA 3 0.0057
89 CORNEAL EROSION 3 0.0056
90 BLEEDING VARICOSE VEIN 3 0.0055
91 BLEPHARITIS 22 0.0055
92 NEPHROGENIC ANAEMIA 24 0.0052
93 OPTIC NERVE INJURY 6 0.0052
94 CORNEAL EPITHELIUM DEFECT 3 0.0052
95 EYE BURNS 3 0.0051
96 ELECTRIC SHOCK SENSATION 14 0.0050
97 PROCTITIS ULCERATIVE 3 0.0050
98 DYSMETRIA 3 0.0050
99 PRODUCT CONTAINER ISSUE 42 0.0049
100 HYPERPARATHYROIDISM SECONDARY 12 0.0048
101 BACILLUS INFECTION 3 0.0047
102 ULCERATIVE KERATITIS 13 0.0047
103 EYE INFLAMMATION 45 0.0047
104 RETINAL DEGENERATION 6 0.0046
105 CHONDROCALCINOSIS 3 0.0046
106 HYPERAEMIA 9 0.0046
107 ACUTE CHEST SYNDROME 4 0.0046
108 EYELID MARGIN CRUSTING 13 0.0045
109 CORNEAL OPACITY 6 0.0044
110 FOREIGN BODY SENSATION IN EYES 28 0.0044
111 SCROTAL SWELLING 4 0.0043
112 IRITIS 13 0.0043
113 PRODUCT MONITORING ERROR 6 0.0042
114 RETINAL VASCULAR OCCLUSION 3 0.0041
115 OCULAR HYPERAEMIA 192 0.0040
116 EYELID IRRITATION 10 0.0040
117 VITREOUS HAEMORRHAGE 11 0.0040
118 SMALL INTESTINAL HAEMORRHAGE 8 0.0040
119 PRODUCT CLOSURE REMOVAL DIFFICULT 4 0.0039
120 METAMORPHOPSIA 7 0.0038
121 TOXIC ANTERIOR SEGMENT SYNDROME 4 0.0037
122 SUBRETINAL FLUID 4 0.0037
123 SUPERFICIAL INJURY OF EYE 4 0.0037
124 OCULAR TOXICITY 4 0.0036
125 NON-INFECTIOUS ENDOPHTHALMITIS 3 0.0035
126 EYE IRRITATION 199 0.0035
127 DETACHMENT OF RETINAL PIGMENT EPITHELIUM 3 0.0034
128 ENDOPHTHALMITIS 20 0.0033
129 PNEUMONIA KLEBSIELLA 6 0.0033
130 VITREOUS FLOATERS 32 0.0033
131 VITREOUS DETACHMENT 7 0.0032
132 CLOSTRIDIUM TEST POSITIVE 7 0.0032
133 EYE PAIN 179 0.0032
134 BLOOD PRESSURE DIASTOLIC ABNORMAL 8 0.0031
135 BLINDNESS UNILATERAL 44 0.0031
136 HYPOTONIA 31 0.0031
137 UVEITIS 42 0.0031
138 ERYTHEMA OF EYELID 16 0.0030
139 EYE COLOUR CHANGE 3 0.0029
140 CAROTID ARTERIOSCLEROSIS 3 0.0029
141 MEDICAL DEVICE REMOVAL 5 0.0029
142 DERMATITIS EXFOLIATIVE GENERALISED 10 0.0029
143 BLOOD PRESSURE SYSTOLIC ABNORMAL 7 0.0028
144 DUODENAL ULCER HAEMORRHAGE 8 0.0028
145 OBSTRUCTIVE SLEEP APNOEA SYNDROME 4 0.0027
146 ESSENTIAL HYPERTENSION 5 0.0027
147 ACUTE ABDOMEN 4 0.0027
148 DRY AGE-RELATED MACULAR DEGENERATION 3 0.0027
149 AORTIC DILATATION 3 0.0027
150 VITRITIS 5 0.0027
151 RETINAL DISORDER 7 0.0027
152 HYPOTHERMIA 27 0.0027
153 ASTIGMATISM 4 0.0026
154 DENGUE FEVER 6 0.0026
155 RETINAL OEDEMA 5 0.0026
156 RETINAL DETACHMENT 24 0.0026
157 ALLODYNIA 3 0.0026
158 PNEUMONIA LEGIONELLA 4 0.0025
159 OPTIC ATROPHY 4 0.0025
160 INTRAVENTRICULAR HAEMORRHAGE 6 0.0024
161 HYPERSENSITIVITY 443 0.0024
162 VISUAL FIELD DEFECT 17 0.0024
163 REBOUND ACID HYPERSECRETION 7 0.0023
164 HYPOPITUITARISM 4 0.0023
165 PRODUCT CONTAINER SEAL ISSUE 4 0.0023
166 HERPES OPHTHALMIC 3 0.0023
167 OCULAR DISCOMFORT 25 0.0022
168 OPHTHALMIC HERPES ZOSTER 4 0.0022
169 EYE OPERATION 10 0.0022
170 LYMPH NODE PAIN 4 0.0021
171 BRONCHIAL OBSTRUCTION 3 0.0021
172 EYE PRURITUS 71 0.0021
173 CONJUNCTIVITIS 39 0.0021
174 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 8 0.0021
175 CONJUNCTIVAL HAEMORRHAGE 8 0.0021
176 SWELLING OF EYELID 13 0.0021
177 CYTOMEGALOVIRUS CHORIORETINITIS 4 0.0020
178 RESPIRATORY ACIDOSIS 8 0.0020
179 EYE DISCHARGE 21 0.0020
180 EYELID PAIN 4 0.0020
181 VISUAL ACUITY REDUCED 64 0.0019
182 ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD 13 0.0019
183 HYPOXIC-ISCHAEMIC ENCEPHALOPATHY 5 0.0019
184 EYE CONTUSION 4 0.0019
185 OPTIC NEUROPATHY 4 0.0019
186 RETINAL HAEMORRHAGE 13 0.0018
187 PHOTOPHOBIA 34 0.0018
188 MEAN CELL HAEMOGLOBIN CONCENTRATION DECREASED 3 0.0018
189 MYOCARDIAL NECROSIS MARKER INCREASED 3 0.0018
190 CEREBRAL HAEMATOMA 6 0.0018
191 RENAL COLIC 4 0.0018
192 DIABETIC RETINOPATHY 6 0.0018
193 BLOOD LOSS ANAEMIA 4 0.0018
194 PHOTOPSIA 11 0.0017
195 PUPIL FIXED 3 0.0017
196 FINE MOTOR SKILL DYSFUNCTION 5 0.0017
197 OTORRHOEA 3 0.0017
198 END STAGE RENAL DISEASE 31 0.0017
199 JUGULAR VEIN THROMBOSIS 3 0.0017
200 LACRIMATION INCREASED 50 0.0017
201 KERATITIS 5 0.0016
202 HYPERKERATOSIS 9 0.0016
203 VASCULITIS 19 0.0016
204 DRY EYE 81 0.0016
205 RETINAL TEAR 4 0.0016
206 INSTILLATION SITE PAIN 4 0.0016
207 PLASMACYTOMA 3 0.0016
208 RETINOPATHY 6 0.0016
209 EYELIDS PRURITUS 5 0.0016
210 RETINAL ARTERY OCCLUSION 4 0.0016
211 CUSHINGOID 5 0.0016
212 PRODUCT PACKAGING DIFFICULT TO OPEN 4 0.0015
213 DEEP VEIN THROMBOSIS POSTOPERATIVE 3 0.0015
214 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 13 0.0015
215 DEPRESSIVE SYMPTOM 5 0.0014
216 MACULOPATHY 5 0.0014
217 NOCTURIA 17 0.0014
218 MIOSIS 11 0.0014
219 NOSOCOMIAL INFECTION 3 0.0014
220 VISION BLURRED 186 0.0014
221 FREEZING PHENOMENON 5 0.0013
222 EYE INFECTION 15 0.0013
223 CATARACT 79 0.0013
224 EYE INJURY 4 0.0013
225 EYE MOVEMENT DISORDER 9 0.0013
226 EYELID DISORDER 3 0.0013
227 CONCOMITANT DISEASE AGGRAVATED 8 0.0013
228 FLAT AFFECT 3 0.0013
229 ROSACEA 6 0.0013
230 APNOEA 10 0.0013
231 EYE DISORDER 42 0.0013
232 NASAL DRYNESS 8 0.0013
233 EYE HAEMORRHAGE 17 0.0013
234 INGROWING NAIL 3 0.0013
235 MACULAR DEGENERATION 15 0.0013
236 BLINDNESS 51 0.0013
237 HAEMOGLOBIN ABNORMAL 8 0.0012
238 PERIORBITAL SWELLING 7 0.0012
239 DIZZINESS POSTURAL 12 0.0012
240 DERMAL CYST 3 0.0012
241 DEAFNESS NEUROSENSORY 4 0.0012
242 LISTLESS 4 0.0012
243 ATRIOVENTRICULAR BLOCK COMPLETE 8 0.0012
244 WRONG PRODUCT ADMINISTERED 8 0.0012
245 GLUCOSE TOLERANCE IMPAIRED 7 0.0012
246 MEAN CELL VOLUME INCREASED 3 0.0012
247 ABNORMAL SENSATION IN EYE 5 0.0012
248 ONYCHOCLASIS 8 0.0012
249 SQUAMOUS CELL CARCINOMA OF SKIN 7 0.0012
250 HYPOPNOEA 4 0.0012
251 HAEMORRHAGIC STROKE 9 0.0012
252 IMMUNOSUPPRESSION 10 0.0011
253 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 3 0.0011
254 HAEMORRHAGIC DIATHESIS 4 0.0011
255 PRODUCT DELIVERY MECHANISM ISSUE 6 0.0011
256 OPTIC NEURITIS 10 0.0011
257 CHRONIC KIDNEY DISEASE 82 0.0011
258 STREPTOCOCCAL INFECTION 6 0.0011
259 VISUAL IMPAIRMENT 130 0.0010
260 RETINAL VEIN OCCLUSION 3 0.0010
261 HUMERUS FRACTURE 5 0.0010
262 PHARYNGEAL SWELLING 10 0.0010
263 RENAL TUBULAR NECROSIS 10 0.0010
264 PRODUCT USE COMPLAINT 16 0.0010
265 RESPIRATORY RATE INCREASED 9 0.0010
266 HEMIPARESIS 17 0.0010
267 BLOOD PRESSURE FLUCTUATION 24 0.0010
268 METABOLIC ENCEPHALOPATHY 3 0.0010
269 HYPERCAPNIA 3 0.0010
270 SUBARACHNOID HAEMORRHAGE 10 0.0010
271 DIASTOLIC DYSFUNCTION 3 0.0010
272 THERAPY NON-RESPONDER 43 0.0010
273 MUSCLE ATROPHY 12 0.0009
274 PRODUCT PACKAGING ISSUE 9 0.0009
275 EYELID OEDEMA 11 0.0009
276 BLADDER PAIN 3 0.0009
277 RECALLED PRODUCT ADMINISTERED 9 0.0009
278 ABSCESS LIMB 4 0.0009
279 HYPOMAGNESAEMIA 13 0.0009
280 BLOOD MAGNESIUM DECREASED 8 0.0009
281 ASTHENOPIA 5 0.0009
282 ABDOMINAL ABSCESS 4 0.0009
283 PLANTAR FASCIITIS 3 0.0009
284 EYE SWELLING 33 0.0009
285 EYELID PTOSIS 9 0.0009
286 IMMUNE THROMBOCYTOPENIA 4 0.0009
287 LEFT VENTRICULAR FAILURE 3 0.0009
288 UROSEPSIS 8 0.0009
289 LARGE INTESTINE POLYP 6 0.0009
290 MICTURITION DISORDER 3 0.0009
291 FORMICATION 6 0.0009
292 ELECTROLYTE IMBALANCE 10 0.0009
293 SKIN ABRASION 4 0.0008
294 CATARACT OPERATION 5 0.0008
295 ISCHAEMIC STROKE 15 0.0008
296 BRADYCARDIA 44 0.0008
297 SKIN LACERATION 9 0.0008
298 HAEMORRHOIDAL HAEMORRHAGE 4 0.0008
299 HOSPICE CARE 8 0.0008
300 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 6 0.0008
301 HAEMATEMESIS 20 0.0008
302 PARANASAL SINUS HYPERSECRETION 3 0.0008
303 MYOSITIS 7 0.0008
304 REHABILITATION THERAPY 3 0.0008
305 INCOHERENT 5 0.0008
306 ATRIAL FLUTTER 6 0.0008
307 BODY HEIGHT DECREASED 8 0.0007
308 LOCALISED INFECTION 18 0.0007
309 PRODUCT RESIDUE PRESENT 4 0.0007
310 DRY MOUTH 60 0.0007
311 RESPIRATORY DEPRESSION 9 0.0007
312 RED CELL DISTRIBUTION WIDTH INCREASED 3 0.0007
313 DEFAECATION URGENCY 5 0.0007
314 BLOOD CALCIUM DECREASED 8 0.0007
315 AORTIC VALVE INCOMPETENCE 3 0.0007
316 POOR PERIPHERAL CIRCULATION 3 0.0007
317 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 12 0.0007
318 INFLAMMATION 36 0.0007
319 PRODUCT ADMINISTRATION ERROR 14 0.0007
320 DRY THROAT 7 0.0007
321 HYPOCALCAEMIA 13 0.0007
322 INTENTIONAL DEVICE MISUSE 3 0.0007
323 DECREASED INTEREST 4 0.0007
324 BLINDNESS TRANSIENT 5 0.0007
325 DRUG INTOLERANCE 65 0.0007
326 CARDIAC PACEMAKER INSERTION 4 0.0007
327 GOUT 12 0.0007
328 TRANSFUSION 7 0.0007
329 PAPILLOEDEMA 3 0.0007
330 HEART RATE DECREASED 23 0.0007
331 BUNDLE BRANCH BLOCK RIGHT 3 0.0007
332 HALLUCINATION 49 0.0006
333 IRON DEFICIENCY ANAEMIA 6 0.0006
334 BLOOD PRESSURE DIASTOLIC INCREASED 3 0.0006
335 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 4 0.0006
336 PRODUCT DISTRIBUTION ISSUE 6 0.0006
337 HAEMOPTYSIS 18 0.0006
338 OESOPHAGITIS 7 0.0006
339 HEPATOCELLULAR INJURY 9 0.0006
340 BLOOD URINE PRESENT 12 0.0006
341 INTENTIONAL DOSE OMISSION 18 0.0006
342 PULSE ABSENT 3 0.0006
343 MYDRIASIS 8 0.0006
344 SINUS BRADYCARDIA 6 0.0006
345 UNRESPONSIVE TO STIMULI 16 0.0006
346 EAR PAIN 12 0.0006
347 DECUBITUS ULCER 5 0.0006
348 INCORRECT DOSAGE ADMINISTERED 3 0.0006
349 WALKING AID USER 4 0.0006
350 DEPRESSED LEVEL OF CONSCIOUSNESS 24 0.0006
351 ARTERIOSCLEROSIS CORONARY ARTERY 4 0.0006
352 HYPERNATRAEMIA 3 0.0006
353 ACUTE KIDNEY INJURY 92 0.0006
354 HYPERAMMONAEMIA 3 0.0006
355 POSTOPERATIVE WOUND INFECTION 4 0.0006
356 FEMORAL NECK FRACTURE 3 0.0006
357 VITAMIN D DECREASED 5 0.0006
358 BENIGN PROSTATIC HYPERPLASIA 3 0.0006
359 SNEEZING 13 0.0006
360 PSYCHOLOGICAL TRAUMA 5 0.0006
361 HAIR GROWTH ABNORMAL 4 0.0006
362 CELLULITIS 29 0.0006
363 RESPIRATORY SYNCYTIAL VIRUS INFECTION 5 0.0006
364 MASS 8 0.0006
365 LYMPHOPENIA 8 0.0006
366 FEAR OF INJECTION 4 0.0006
367 GASTROINTESTINAL MOTILITY DISORDER 3 0.0006
368 RED BLOOD CELL COUNT DECREASED 16 0.0006
369 GINGIVITIS 3 0.0006
370 PULMONARY THROMBOSIS 6 0.0005
371 GASTROENTERITIS 8 0.0005
372 INTENTIONAL UNDERDOSE 4 0.0005
373 DRUG LEVEL BELOW THERAPEUTIC 3 0.0005
374 FEELING COLD 15 0.0005
375 RENAL INJURY 16 0.0005
376 BACTERIAL INFECTION 10 0.0005
377 UPPER GASTROINTESTINAL HAEMORRHAGE 9 0.0005
378 RIB FRACTURE 11 0.0005
379 ATRIAL FIBRILLATION 52 0.0005
380 FLANK PAIN 5 0.0005
381 METABOLIC ACIDOSIS 17 0.0005
382 SQUAMOUS CELL CARCINOMA 5 0.0005
383 INTERNAL HAEMORRHAGE 6 0.0005
384 CARDIAC VALVE DISEASE 3 0.0005
385 BOWEL MOVEMENT IRREGULARITY 4 0.0005
386 SUPRAVENTRICULAR TACHYCARDIA 5 0.0005
387 HALLUCINATION, VISUAL 11 0.0005
388 HERPES VIRUS INFECTION 3 0.0005
389 BALANCE DISORDER 45 0.0005
390 ORTHOSTATIC HYPOTENSION 9 0.0005
391 ANKLE FRACTURE 8 0.0005
392 TACHYPNOEA 7 0.0005
393 AUTOIMMUNE DISORDER 5 0.0005
394 VITAMIN D DEFICIENCY 5 0.0005
395 PERIPHERAL COLDNESS 7 0.0005
396 THERAPY CHANGE 5 0.0005
397 COVID-19 PNEUMONIA 6 0.0005
398 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 3 0.0005
399 FALL 168 0.0005
400 RENAL FAILURE 67 0.0005
401 SKIN ULCER 13 0.0005
402 DEMENTIA 14 0.0005
403 BLOOD TEST ABNORMAL 7 0.0005
404 PLATELET COUNT ABNORMAL 3 0.0005
405 BACK DISORDER 8 0.0005
406 INTERNATIONAL NORMALISED RATIO INCREASED 14 0.0005
407 MENISCUS INJURY 3 0.0005
408 IMPAIRED QUALITY OF LIFE 7 0.0005
409 PHARYNGITIS 6 0.0005
410 HYPOXIA 17 0.0005
411 VENTRICULAR EXTRASYSTOLES 5 0.0005
412 FREQUENT BOWEL MOVEMENTS 13 0.0005
413 PRE-EXISTING CONDITION IMPROVED 3 0.0005
414 WEIGHT FLUCTUATION 5 0.0005
415 LETHARGY 27 0.0005
416 URINARY TRACT INFECTION 80 0.0005
417 CHOLESTASIS 9 0.0005
418 POST PROCEDURAL COMPLICATION 9 0.0005
419 HAEMORRHAGE INTRACRANIAL 7 0.0005
420 MENTAL STATUS CHANGES 13 0.0005
421 PERIPHERAL SWELLING 72 0.0005
422 BLOOD PRESSURE DECREASED 31 0.0005
423 NIGHT SWEATS 15 0.0005
424 CARDIAC FLUTTER 3 0.0005
425 ECONOMIC PROBLEM 7 0.0005
426 BLOOD PRESSURE SYSTOLIC INCREASED 9 0.0005
427 NODULE 6 0.0005
428 BRADYPHRENIA 3 0.0005
429 WOUND INFECTION 5 0.0005
430 GASTRITIS 12 0.0005
431 GROIN PAIN 4 0.0005
432 HAEMATOCRIT DECREASED 9 0.0005
433 APPETITE DISORDER 3 0.0005
434 CONFUSIONAL STATE 73 0.0005
435 ASTHMA 51 0.0005
436 DRUG INEFFECTIVE 592 0.0004
437 BASAL CELL CARCINOMA 7 0.0004
438 HAIR TEXTURE ABNORMAL 6 0.0004
439 ENCEPHALOPATHY 11 0.0004
440 BRAIN FOG 7 0.0004
441 ANAL INCONTINENCE 4 0.0004
442 GASTROENTERITIS VIRAL 8 0.0004
443 ABNORMAL LOSS OF WEIGHT 3 0.0004
444 IMPAIRED DRIVING ABILITY 5 0.0004
445 RESPIRATION ABNORMAL 3 0.0004
446 LYMPHOEDEMA 3 0.0004
447 PERSONALITY CHANGE 4 0.0004
448 EXTRASYSTOLES 3 0.0004
449 ARTERIOSCLEROSIS 4 0.0004
450 RENAL FAILURE ACUTE 18 0.0004
451 DIVERTICULUM 3 0.0004
452 TOXICITY TO VARIOUS AGENTS 71 0.0004
453 NEUTROPENIC SEPSIS 3 0.0004
454 POLYNEUROPATHY 5 0.0004
455 ELECTROCARDIOGRAM QT PROLONGED 15 0.0004
456 HAEMATOCHEZIA 23 0.0004
457 PARAESTHESIA ORAL 6 0.0004
458 AFFECT LABILITY 4 0.0004
459 PULMONARY ARTERIAL HYPERTENSION 6 0.0004
460 ATELECTASIS 4 0.0004
461 PRODUCT PRESCRIBING ISSUE 9 0.0004
462 ADRENAL INSUFFICIENCY 5 0.0004
463 MOUTH HAEMORRHAGE 3 0.0004
464 PSYCHIATRIC SYMPTOM 3 0.0004
465 OEDEMA 22 0.0004
466 URINARY INCONTINENCE 12 0.0004
467 CYST 5 0.0004
468 PULMONARY MASS 6 0.0004
469 INABILITY TO AFFORD MEDICATION 4 0.0004
470 BLOOD PRESSURE ABNORMAL 8 0.0004
471 TREATMENT NONCOMPLIANCE 22 0.0004
472 UPPER LIMB FRACTURE 8 0.0004
473 RASH PAPULAR 9 0.0004
474 LACTIC ACIDOSIS 13 0.0004
475 THROAT IRRITATION 18 0.0004
476 HAEMOGLOBIN DECREASED 41 0.0004
477 DIZZINESS 199 0.0004
478 HOT FLUSH 30 0.0004
479 PRODUCT DOSE OMISSION ISSUE 117 0.0004
480 DERMATITIS ALLERGIC 5 0.0004
481 OXYGEN SATURATION DECREASED 22 0.0004
482 LIP SWELLING 13 0.0004
483 HELICOBACTER INFECTION 4 0.0004
484 GAIT INABILITY 13 0.0004
485 CONCUSSION 3 0.0004
486 SOMNOLENCE 78 0.0004
487 EJECTION FRACTION DECREASED 6 0.0004
488 DIPLOPIA 10 0.0004
489 RESTLESS LEGS SYNDROME 7 0.0004
490 TENDERNESS 4 0.0004
491 PLATELET COUNT INCREASED 5 0.0004
492 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 21 0.0004
493 MULTIPLE ALLERGIES 3 0.0004
494 BLOOD CREATINE PHOSPHOKINASE INCREASED 11 0.0004
495 DERMATITIS 8 0.0004
496 INJECTION SITE DISCOMFORT 4 0.0004
497 FULL BLOOD COUNT ABNORMAL 4 0.0004
498 RESPIRATORY TRACT CONGESTION 6 0.0004
499 CLOSTRIDIUM DIFFICILE COLITIS 4 0.0004
500 PRODUCTIVE COUGH 18 0.0004
501 GINGIVAL PAIN 3 0.0004
502 SCIATICA 6 0.0004
503 MIDDLE INSOMNIA 7 0.0004
504 MALIGNANT MELANOMA 5 0.0004
505 HIP FRACTURE 12 0.0004
506 DYSPNOEA EXERTIONAL 14 0.0004
507 HYPOACUSIS 16 0.0004
508 HYPOGLYCAEMIA 18 0.0004
509 GASTROINTESTINAL HAEMORRHAGE 31 0.0004
510 BLOOD POTASSIUM INCREASED 6 0.0004
511 COLITIS 14 0.0004
512 HYPOTENSION 74 0.0004
513 PALLOR 10 0.0004
514 IMPAIRED GASTRIC EMPTYING 5 0.0004
515 CLOSTRIDIUM DIFFICILE INFECTION 8 0.0004
516 POLYURIA 3 0.0004
517 INTERVERTEBRAL DISC PROTRUSION 8 0.0004
518 HYPERAESTHESIA 3 0.0004
519 ESCHERICHIA INFECTION 3 0.0004
520 GASTROINTESTINAL PAIN 4 0.0004
521 MELAENA 8 0.0004
522 INJECTION SITE NODULE 4 0.0004
523 RESPIRATORY DISTRESS 10 0.0004
524 EMBOLISM 3 0.0004
525 DISCOMFORT 22 0.0004
526 NASAL CONGESTION 21 0.0004
527 ORAL PAIN 8 0.0004
528 THERAPEUTIC RESPONSE UNEXPECTED 16 0.0004
529 INFUSION SITE ERYTHEMA 3 0.0004
530 RHINORRHOEA 23 0.0004
531 REBOUND EFFECT 4 0.0004
532 SEASONAL ALLERGY 5 0.0004
533 PRESCRIBED UNDERDOSE 7 0.0004
534 DERMATITIS CONTACT 4 0.0004
535 SCAB 4 0.0004
536 PARALYSIS 5 0.0003
537 CARDIOGENIC SHOCK 5 0.0003
538 HEAD INJURY 11 0.0003
539 MUSCLE STRAIN 3 0.0003
540 PYELONEPHRITIS 3 0.0003
541 CYSTITIS 11 0.0003
542 RENAL IMPAIRMENT 29 0.0003
543 HYPOKINESIA 5 0.0003
544 DEAFNESS 9 0.0003
545 POST PROCEDURAL HAEMORRHAGE 4 0.0003
546 BLOOD CHOLESTEROL INCREASED 16 0.0003
547 NAIL DISORDER 3 0.0003
548 COUGH 96 0.0003
549 BLOOD CALCIUM INCREASED 3 0.0003
550 SPINAL PAIN 4 0.0003
551 INFLUENZA 38 0.0003
552 BLOOD PRESSURE INCREASED 52 0.0003
553 CARDIOMYOPATHY 5 0.0003
554 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 24 0.0003
555 HYPONATRAEMIA 19 0.0003
556 ATAXIA 4 0.0003
557 BACTERAEMIA 4 0.0003
558 PNEUMONIA 109 0.0003
559 FACIAL PAIN 3 0.0003
560 PULMONARY HYPERTENSION 7 0.0003
561 WRIST FRACTURE 4 0.0003
562 STAPHYLOCOCCAL INFECTION 11 0.0003
563 HEAVY MENSTRUAL BLEEDING 3 0.0003
564 FATIGUE 259 0.0003
565 CONDITION AGGRAVATED 101 0.0003
566 SEPSIS 37 0.0003
567 LIMB INJURY 9 0.0003
568 EXPIRED PRODUCT ADMINISTERED 11 0.0003
569 RESPIRATORY FAILURE 24 0.0003
570 FIBROMYALGIA 8 0.0003
571 NEPHROLITHIASIS 15 0.0003
572 INSURANCE ISSUE 5 0.0003
573 PNEUMONIA BACTERIAL 3 0.0003
574 OFF LABEL USE 286 0.0003
575 TRANSIENT ISCHAEMIC ATTACK 11 0.0003
576 BLOOD THYROID STIMULATING HORMONE INCREASED 3 0.0003
577 CONSTIPATION 71 0.0003
578 GLOMERULAR FILTRATION RATE DECREASED 4 0.0003
579 HYPERCALCAEMIA 4 0.0003
580 GAIT DISTURBANCE 62 0.0003
581 CARDIAC FAILURE CONGESTIVE 26 0.0003
582 THERAPY INTERRUPTED 23 0.0003
583 BLOOD CREATININE INCREASED 21 0.0003
584 NEPHROPATHY 3 0.0003
585 APPENDICITIS 3 0.0003
586 LOSS OF CONSCIOUSNESS 41 0.0003
587 HEPATIC CIRRHOSIS 6 0.0003
588 LEUKAEMIA 3 0.0003
589 PRODUCT DOSE OMISSION IN ERROR 9 0.0003
590 UNEVALUABLE EVENT 24 0.0003
591 FLUID RETENTION 16 0.0003
592 HYPOTHYROIDISM 10 0.0003
593 ACUTE RESPIRATORY FAILURE 6 0.0003
594 OEDEMA PERIPHERAL 38 0.0003
595 ERYTHEMA 64 0.0003
596 DECREASED APPETITE 72 0.0003
597 HEART RATE IRREGULAR 7 0.0003
598 PRODUCT QUALITY ISSUE 42 0.0003
599 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 9 0.0003
600 CHILLS 36 0.0003
601 OSTEOARTHRITIS 13 0.0003
602 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 16 0.0003
603 MEMORY IMPAIRMENT 42 0.0003
604 MUSCULOSKELETAL PAIN 16 0.0003
605 IMPAIRED HEALING 10 0.0003
606 WEIGHT DECREASED 85 0.0003
607 ANKYLOSING SPONDYLITIS 4 0.0003
608 PERICARDIAL EFFUSION 7 0.0003
609 BLISTER 17 0.0003
610 BLADDER DISORDER 3 0.0003
611 HYPERGLYCAEMIA 11 0.0003
612 CONTUSION 29 0.0003
613 RESPIRATORY DISORDER 9 0.0003
614 DEHYDRATION 40 0.0003
615 SPINAL FRACTURE 6 0.0003
616 BLOOD POTASSIUM DECREASED 9 0.0003
617 CYTOKINE RELEASE SYNDROME 6 0.0003
618 DYSURIA 11 0.0003
619 PARAESTHESIA 47 0.0003
620 INTENTIONAL PRODUCT USE ISSUE 26 0.0003
621 HERPES ZOSTER 17 0.0003
622 DISEASE PROGRESSION 35 0.0003
623 RASH PRURITIC 16 0.0003
624 NEUROPATHY PERIPHERAL 28 0.0003
625 NEUTROPHIL COUNT INCREASED 3 0.0003
626 ARTHRITIS 23 0.0003
627 EAR DISCOMFORT 3 0.0003
628 DYSARTHRIA 11 0.0003
629 PULMONARY OEDEMA 13 0.0003
630 ASTHENIA 109 0.0003
631 NIGHTMARE 10 0.0003
632 DIVERTICULITIS 8 0.0003
633 HYPERTENSION 61 0.0003
634 ORAL DISCOMFORT 4 0.0003
635 POLLAKIURIA 12 0.0003
636 PRODUCT ODOUR ABNORMAL 3 0.0003
637 LUNG DISORDER 14 0.0003
638 INCONTINENCE 3 0.0003
639 ANAEMIA 54 0.0003
640 TINNITUS 13 0.0003
641 PLASMA CELL MYELOMA 11 0.0003
642 EATING DISORDER 6 0.0003
643 JOINT SWELLING 34 0.0003
644 HYPOKALAEMIA 13 0.0003
645 MUSCULAR WEAKNESS 32 0.0003
646 DIARRHOEA 181 0.0003
647 MOVEMENT DISORDER 9 0.0003
648 PNEUMONIA ASPIRATION 7 0.0003
649 RECTAL HAEMORRHAGE 12 0.0003
650 POOR QUALITY SLEEP 6 0.0003
651 PRODUCT SUBSTITUTION ISSUE 16 0.0003
652 TREMOR 46 0.0003
653 FAECES DISCOLOURED 6 0.0003
654 OSTEOMYELITIS 5 0.0003
655 BACK INJURY 3 0.0003
656 FLUID OVERLOAD 4 0.0003
657 GASTROOESOPHAGEAL REFLUX DISEASE 22 0.0003
658 SURGERY 16 0.0003
659 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 5 0.0003
660 EXTRA DOSE ADMINISTERED 11 0.0003
661 ACUTE MYOCARDIAL INFARCTION 8 0.0003
662 RED BLOOD CELL SEDIMENTATION RATE INCREASED 3 0.0003
663 BLOOD GLUCOSE DECREASED 13 0.0003
664 DYSKINESIA 11 0.0003
665 BRONCHITIS 20 0.0003
666 FUNGAL INFECTION 9 0.0003
667 WHEEZING 16 0.0003
668 OBSTRUCTIVE AIRWAYS DISORDER 3 0.0003
669 MALNUTRITION 3 0.0003
670 TUBULOINTERSTITIAL NEPHRITIS 5 0.0003
671 PRURITUS 102 0.0003
672 HYPOAESTHESIA ORAL 4 0.0003
673 BLOOD SODIUM DECREASED 5 0.0003
674 MITRAL VALVE INCOMPETENCE 3 0.0003
675 DYSPNOEA 150 0.0003
676 CONTRAINDICATED PRODUCT ADMINISTERED 8 0.0003
677 FRACTURE 5 0.0003
678 GASTRIC ULCER 5 0.0003
679 PROTEINURIA 5 0.0003
680 MICTURITION URGENCY 3 0.0003
681 MYOCARDITIS 3 0.0003
682 PRODUCT DOSE OMISSION 17 0.0003
683 UNDERDOSE 19 0.0003
684 THYROID DISORDER 4 0.0003
685 MUSCULOSKELETAL CHEST PAIN 4 0.0003
686 ERUCTATION 5 0.0003
687 HEADACHE 162 0.0003
688 DELUSION 4 0.0003
689 PNEUMONITIS 7 0.0003
690 BURNING SENSATION 18 0.0003
691 THERAPY PARTIAL RESPONDER 4 0.0003
692 CHOKING 5 0.0003
693 ORAL HERPES 5 0.0003
694 PRODUCT USE ISSUE 48 0.0003
695 CARDIAC ARREST 21 0.0003
696 CYANOSIS 4 0.0003
697 PRODUCT USE IN UNAPPROVED INDICATION 63 0.0003
698 EPISTAXIS 19 0.0003
699 ARRHYTHMIA 12 0.0003
700 ULCER 4 0.0003
701 HYPERLIPIDAEMIA 3 0.0003
702 WOUND 7 0.0003
703 SYNCOPE 25 0.0002
704 CARDIAC FAILURE 20 0.0002
705 NERVOUSNESS 13 0.0002
706 PRODUCT PHYSICAL ISSUE 5 0.0002
707 DRUG EFFECT INCOMPLETE 9 0.0002
708 THERAPEUTIC RESPONSE DECREASED 15 0.0002
709 FLATULENCE 14 0.0002
710 NEURALGIA 6 0.0002
711 DEEP VEIN THROMBOSIS 16 0.0002
712 SWELLING 23 0.0002
713 INJURY ASSOCIATED WITH DEVICE 5 0.0002
714 HYPERSOMNIA 7 0.0002
715 CARDIOMEGALY 3 0.0002
716 HEART RATE INCREASED 24 0.0002
717 VENTRICULAR TACHYCARDIA 4 0.0002
718 SLEEP DISORDER 17 0.0002
719 AGEUSIA 6 0.0002
720 COAGULOPATHY 4 0.0002
721 DRY SKIN 32 0.0002
722 DRUG INTERACTION 38 0.0002
723 BLOOD UREA INCREASED 4 0.0002
724 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 43 0.0002
725 KNEE ARTHROPLASTY 5 0.0002
726 INSOMNIA 63 0.0002
727 INFECTION 34 0.0002
728 HYPOPHAGIA 6 0.0002
729 JOINT INJURY 5 0.0002
730 MEDICATION ERROR 13 0.0002
731 SEIZURE 27 0.0002
732 HAEMATURIA 8 0.0002
733 GENERAL PHYSICAL HEALTH DETERIORATION 27 0.0002
734 ABDOMINAL DISCOMFORT 39 0.0002
735 APHASIA 7 0.0002
736 DYSPHAGIA 22 0.0002
737 RASH 101 0.0002
738 PALPITATIONS 27 0.0002
739 SWELLING FACE 15 0.0002
740 PLEURAL EFFUSION 14 0.0002
741 SEPTIC SHOCK 10 0.0002
742 INCORRECT DOSE ADMINISTERED BY DEVICE 6 0.0002
743 DYSGEUSIA 17 0.0002
744 RASH MACULAR 8 0.0002
745 DEVICE USE ISSUE 4 0.0002
746 DEPRESSION 52 0.0002
747 ANHEDONIA 6 0.0002
748 INCORRECT PRODUCT STORAGE 3 0.0002
749 BEDRIDDEN 3 0.0002
750 DRUG ADMINISTRATION ERROR 7 0.0002
751 ORAL CANDIDIASIS 3 0.0002
752 PAIN IN EXTREMITY 67 0.0002
753 OROPHARYNGEAL PAIN 21 0.0002
754 INFUSION RELATED REACTION 15 0.0002
755 LIMB DISCOMFORT 7 0.0002
756 FEMUR FRACTURE 7 0.0002
757 CARDIAC DISORDER 21 0.0002
758 THROMBOSIS 18 0.0002
759 DYSPEPSIA 22 0.0002
760 ACCIDENTAL EXPOSURE TO PRODUCT 23 0.0002
761 NASOPHARYNGITIS 41 0.0002
762 NAUSEA 176 0.0002
763 HAEMORRHAGE 23 0.0002
764 BACK PAIN 51 0.0002
765 LUNG NEOPLASM MALIGNANT 9 0.0002
766 OSTEOPOROSIS 9 0.0002
767 CORONARY ARTERY OCCLUSION 3 0.0002
768 AMNESIA 14 0.0002
769 APHONIA 3 0.0002
770 CHEST DISCOMFORT 22 0.0002
771 PANCYTOPENIA 12 0.0002
772 RENAL DISORDER 10 0.0002
773 TACHYCARDIA 19 0.0002
774 ABDOMINAL PAIN UPPER 44 0.0002
775 CHOLELITHIASIS 7 0.0002
776 VERTIGO 13 0.0002
777 DEVICE OCCLUSION 3 0.0002
778 GASTROINTESTINAL DISORDER 19 0.0002
779 PAIN IN JAW 6 0.0002
780 COVID-19 37 0.0002
781 ABDOMINAL DISTENSION 22 0.0002
782 COMA 10 0.0002
783 PRODUCT PRESCRIBING ERROR 5 0.0002
784 FEELING JITTERY 4 0.0002
785 URINARY RETENTION 7 0.0002
786 SLEEP APNOEA SYNDROME 4 0.0002
787 ALOPECIA 41 0.0002
788 PULMONARY FIBROSIS 4 0.0002
789 DIABETIC KETOACIDOSIS 5 0.0002
790 PANCREATITIS 11 0.0002
791 TYPE 2 DIABETES MELLITUS 7 0.0002
792 HYPERTHYROIDISM 3 0.0002
793 HYPOAESTHESIA 31 0.0002
794 CEREBROVASCULAR ACCIDENT 35 0.0002
795 PRESYNCOPE 5 0.0002
796 WEIGHT INCREASED 46 0.0002
797 DYSPHONIA 12 0.0002
798 CHEST PAIN 38 0.0002
799 DISTURBANCE IN ATTENTION 11 0.0002
800 VOMITING 95 0.0002
801 SINUS DISORDER 4 0.0002
802 HYPERHIDROSIS 26 0.0002
803 MUSCLE SPASMS 37 0.0002
804 SKIN EXFOLIATION 17 0.0002
805 COLON CANCER 3 0.0002
806 HYPERKALAEMIA 7 0.0002
807 ANAPHYLACTIC REACTION 11 0.0002
808 PSORIASIS 26 0.0002
809 FULL BLOOD COUNT DECREASED 4 0.0002
810 GLYCOSYLATED HAEMOGLOBIN INCREASED 5 0.0002
811 ARTHROPATHY 11 0.0002
812 OSTEOPENIA 3 0.0002
813 TASTE DISORDER 4 0.0002
814 INCORRECT DOSE ADMINISTERED 45 0.0002
815 DEVICE FAILURE 3 0.0002
816 NECK PAIN 11 0.0002
817 DIABETES MELLITUS 15 0.0002
818 EPILEPSY 6 0.0002
819 FEELING HOT 12 0.0002
820 CEREBRAL HAEMORRHAGE 7 0.0002
821 DEVICE RELATED INFECTION 3 0.0002
822 THERAPY CESSATION 10 0.0002
823 UPPER RESPIRATORY TRACT INFECTION 9 0.0002
824 ABDOMINAL PAIN 45 0.0002
825 NO ADVERSE EVENT 35 0.0002
826 LUNG INFECTION 3 0.0002
827 BONE DENSITY DECREASED 6 0.0002
828 SPEECH DISORDER 10 0.0002
829 DERMATITIS ATOPIC 10 0.0002
830 INJECTION SITE MASS 7 0.0002
831 PNEUMOTHORAX 3 0.0002
832 HALLUCINATION, AUDITORY 3 0.0002
833 RASH ERYTHEMATOUS 9 0.0002
834 BONE PAIN 11 0.0002
835 PLATELET COUNT DECREASED 20 0.0002
836 ARTHRALGIA 78 0.0002
837 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 38 0.0002
838 MALAISE 82 0.0002
839 SKIN CANCER 4 0.0002
840 PRODUCT DISPENSING ERROR 4 0.0002
841 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 13 0.0002
842 WHITE BLOOD CELL COUNT INCREASED 7 0.0002
843 PHOTOSENSITIVITY REACTION 3 0.0002
844 GENERALISED TONIC-CLONIC SEIZURE 3 0.0002
845 ABNORMAL DREAMS 5 0.0002
846 BLOOD GLUCOSE INCREASED 34 0.0002
847 DEATH 155 0.0002
848 TOOTH DISORDER 4 0.0002
849 RASH MACULO-PAPULAR 4 0.0002
850 INJECTION SITE PRURITUS 12 0.0002
851 THERAPEUTIC PRODUCT EFFECT DECREASED 8 0.0002
852 FACE OEDEMA 3 0.0002
853 ANGER 6 0.0002
854 CHROMATURIA 4 0.0002
855 PYREXIA 61 0.0002
856 RHEUMATOID ARTHRITIS 20 0.0002
857 HEPATIC ENZYME INCREASED 12 0.0002
858 HOSPITALISATION 27 0.0002
859 PRODUCT AVAILABILITY ISSUE 4 0.0002
860 ANGINA PECTORIS 5 0.0002
861 SKIN DISCOLOURATION 8 0.0002
862 SHOCK 4 0.0002
863 MULTI-ORGAN FAILURE 3 0.0002
864 DEVICE DEFECTIVE 3 0.0002
865 LIVER FUNCTION TEST ABNORMAL 5 0.0002
866 NEEDLE ISSUE 5 0.0002
867 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 4 0.0002
868 DYSSTASIA 5 0.0002
869 DIABETES MELLITUS INADEQUATE CONTROL 3 0.0002
870 HEAD DISCOMFORT 3 0.0002
871 CARDIO-RESPIRATORY ARREST 7 0.0002
872 MOBILITY DECREASED 12 0.0002
873 ADVERSE DRUG REACTION 15 0.0002
874 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 8 0.0002
875 IRRITABILITY 10 0.0002
876 PAIN 102 0.0002
877 LEUKOCYTOSIS 3 0.0002
878 BONE DISORDER 3 0.0002
879 AGITATION 12 0.0002
880 EMOTIONAL DISORDER 5 0.0002
881 ABASIA 4 0.0002
882 EXTRAPYRAMIDAL DISORDER 4 0.0002
883 HEPATIC STEATOSIS 3 0.0002
884 NERVOUS SYSTEM DISORDER 5 0.0002
885 INTESTINAL OBSTRUCTION 6 0.0002
886 FOOT FRACTURE 3 0.0002
887 PRODUCT COMPLAINT 4 0.0002
888 WHITE BLOOD CELL COUNT DECREASED 17 0.0002
889 DEVICE ISSUE 14 0.0002
890 HERNIA 3 0.0002
891 ANXIETY 44 0.0002
892 RASH GENERALISED 4 0.0002
893 HAEMATOMA 4 0.0002
894 HAEMORRHOIDS 3 0.0002
895 MYALGIA 26 0.0002
896 KIDNEY INFECTION 3 0.0002
897 SKIN IRRITATION 7 0.0002
898 THROMBOCYTOPENIA 17 0.0002
899 DISORIENTATION 6 0.0002
900 DEPRESSED MOOD 8 0.0002
901 EAR INFECTION 4 0.0002
902 SKIN DISORDER 5 0.0001
903 MYOCARDIAL INFARCTION 26 0.0001
904 STOMATITIS 9 0.0001
905 MUSCULOSKELETAL STIFFNESS 13 0.0001
906 THROAT TIGHTNESS 4 0.0001
907 PULMONARY EMBOLISM 14 0.0001
908 MALIGNANT NEOPLASM PROGRESSION 15 0.0001
909 SINUSITIS 15 0.0001
910 DEVICE DELIVERY SYSTEM ISSUE 4 0.0001
911 FEELING ABNORMAL 35 0.0001
912 INFLUENZA LIKE ILLNESS 12 0.0001
913 RESPIRATORY ARREST 4 0.0001
914 ACNE 11 0.0001
915 DELIRIUM 5 0.0001
916 MOUTH ULCERATION 3 0.0001
917 RETCHING 3 0.0001
918 INCORRECT ROUTE OF DRUG ADMINISTRATION 5 0.0001
919 NEUTROPENIA 19 0.0001
920 DEVICE DISLOCATION 6 0.0001
921 FLUSHING 14 0.0001
922 PRODUCT STORAGE ERROR 12 0.0001
923 INTENTIONAL PRODUCT MISUSE 12 0.0001
924 ACCIDENTAL OVERDOSE 5 0.0001
925 RESTLESSNESS 5 0.0001
926 FEBRILE NEUTROPENIA 9 0.0001
927 PANCREATITIS ACUTE 3 0.0001
928 DRUG DOSE OMISSION 22 0.0001
929 ASPARTATE AMINOTRANSFERASE INCREASED 7 0.0001
930 MUSCLE TWITCHING 3 0.0001
931 COGNITIVE DISORDER 6 0.0001
932 SWOLLEN TONGUE 4 0.0001
933 ABNORMAL BEHAVIOUR 5 0.0001
934 ILLNESS 13 0.0001
935 DISEASE RECURRENCE 6 0.0001
936 EMOTIONAL DISTRESS 15 0.0001
937 PSORIATIC ARTHROPATHY 5 0.0001
938 VIRAL INFECTION 4 0.0001
939 AGGRESSION 6 0.0001
940 URTICARIA 20 0.0001
941 ADVERSE EVENT 11 0.0001
942 WITHDRAWAL SYNDROME 5 0.0001
943 CARDIOVASCULAR DISORDER 3 0.0001
944 ERECTILE DYSFUNCTION 3 0.0001
945 GASTRIC DISORDER 4 0.0001
946 EXPOSURE VIA SKIN CONTACT 3 0.0001
947 VAGINAL HAEMORRHAGE 5 0.0001
948 RESPIRATORY TRACT INFECTION 3 0.0001
949 NEOPLASM PROGRESSION 4 0.0001
950 ECZEMA 6 0.0001
951 JOINT STIFFNESS 3 0.0001
952 ALANINE AMINOTRANSFERASE INCREASED 7 0.0001
953 INJECTION SITE HAEMORRHAGE 9 0.0001
954 FEAR 3 0.0001
955 INJECTION SITE PAIN 34 0.0001
956 MOOD ALTERED 3 0.0001
957 PROCEDURAL PAIN 3 0.0001
958 PANCREATIC CARCINOMA 3 0.0001
959 ASCITES 3 0.0001
960 LABORATORY TEST ABNORMAL 3 0.0001
961 LEUKOPENIA 5 0.0001
962 HEPATIC FAILURE 3 0.0001
963 NEUTROPHIL COUNT DECREASED 4 0.0001
964 ROAD TRAFFIC ACCIDENT 4 0.0001
965 MIGRAINE 9 0.0001
966 MENTAL DISORDER 4 0.0001
967 INJECTION SITE SWELLING 7 0.0001
968 DEVICE DIFFICULT TO USE 6 0.0001
969 NEOPLASM MALIGNANT 6 0.0001
970 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 3 0.0001
971 INJECTION SITE BRUISING 7 0.0001
972 CONVULSION 5 0.0001
973 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 4 0.0001
974 DEVICE MALFUNCTION 6 0.0001
975 INJURY 6 0.0001
976 LYMPHADENOPATHY 3 0.0001
977 SKIN BURNING SENSATION 6 0.0001
978 INTERSTITIAL LUNG DISEASE 4 0.0001
979 ILL-DEFINED DISORDER 5 0.0001
980 DRUG WITHDRAWAL SYNDROME 7 0.0001
981 DRUG EFFECT DECREASED 4 0.0001
982 OVERDOSE 16 0.0001
983 MULTIPLE SCLEROSIS RELAPSE 5 0.0001
984 DEVICE LEAKAGE 3 0.0001
985 LIVER DISORDER 3 0.0001
986 COLITIS ULCERATIVE 3 0.0001
987 SUICIDAL IDEATION 6 0.0001
988 EXPOSURE DURING PREGNANCY 4 0.0001
989 INJECTION SITE REACTION 4 0.0001
990 INJECTION SITE ERYTHEMA 7 0.0001
991 PROSTATE CANCER 4 0.0000
992 MATERNAL EXPOSURE DURING PREGNANCY 4 0.0000